| A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy |
|
|
|
|
|
|
|
|
|
| Familial colorectal cancer referral to regional genetics department—a single centre experience |
|
|
|
|
|
|
|
|
|
| An association between the 4G polymorphism in the PAI-1 promoter and the development of aggressive fibromatosis (desmoid tumor) in familial adenomatous polyposis patients |
|
|
|
|
|
|
|
|
|
| Study comparing two types of screening provision for people with von Hippel-Lindau disease |
|
|
|
|
|
|
|
|
|
| Improved survival in BRCA2 carriers with ovarian cancer |
|
|
|
|
|
|
|
|
|
| A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene |
|
|
|
|
|
|
|
|
|
| Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred |
|
|
|
|
|
|
|
|
|
| The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome |
|
|
|
|
|
|
|
|
|
| The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family |
|
|
|
|
|
|
|
|
|
| Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies |
|
|
|
|
|
|
|
|
|
| Invited Commentary |
|
|
|
|
|
|
|
|
|
| In which patients do I perform IRA, and why? |
|
|
|
|
|
|
|
|
|
| Invited commentary |
|
|
|
|
|
|
|
|
|
| Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis |
|
|
|
|
|
|
|
|
|
| Foreword: The future for the study of familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited |
|
|
|
|
|
|
|
|
|
| The genetics of FAP and FAP-like syndromes |
|
|
|
|
|
|
|
|
|
| Familial adenomatous polyposis: the practical applications of clinical and molecular screening |
|
|
|
|
|
|
|
|
|
| Current ideas in desmoid tumours |
|
|
|
|
|
|
|
|
|
| The current status of chemoprevention in FAP |
|
|
|
|
|
|
|
|
|
| Invited Commentary |
|
|
|
|
|
|
|
|
|
| The history of familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| The 471delAAAG Mutation and C353T Polymorphism in the RNASEL Gene in Sporadic and Inherited Cancer in Israel |
|
|
|
|
|
|
|
|
|
| Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer |
|
|
|
|
|
|
|
|
|
| Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from Western Sweden |
|
|
|
|
|
|
|
|
|
| Heterozygote BRCA1 status and skewed chromosome X inactivation |
|
|
|
|
|
|
|
|
|
| Molecular diagnosis of neurofibromatosis type 1: 2 years experience |
|
|
|
|
|
|
|
|
|
| Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene |
|
|
|
|
|
|
|
|
|
| Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families |
|
|
|
|
|
|
|
|
|
| The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC) |
|
|
|
|
|
|
|
|
|
| Low Frequency of CHEK2 Mutations in Familial Pancreatic Cancer |
|
|
|
|
|
|
|
|
|
| Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County |
|
|
|
|
|
|
|
|
|
| Screening behavior in women at increased familial risk for breast cancer |
|
|
|
|
|
|
|
|
|
| The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer |
|
|
|
|
|
|
|
|
|
| Survival from Colorectal Carcinoma in HNPCC Families as Compared to the General Population in Lithuania – Initial Results |
|
|
|
|
|
|
|
|
|
| What is the appropriate screening protocol in Lynch syndrome? |
|
|
|
|
|
|
|
|
|
| BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families |
|
|
|
|
|
|
|
|
|
| Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations |
|
|
|
|
|
|
|
|
|
| Differences of Onset Age and Survival Rates in Esophageal Squamous Cell Carcinoma Cases with and without Family History of Upper Gastrointestinal Cancer from a High-incidence Area in North China |
|
|
|
|
|
|
|
|
|
| Low Prevalence of BRCA1 Exon Rearrangements in Familial and Young Sporadic Breast Cancer Patients |
|
|
|
|
|
|
|
|
|
| Acceptance of Preventive Surgeries by Israeli Women Who had Undergone BRCA Testing |
|
|
|
|
|
|
|
|
|
| Accuracy of BRCA1 and BRCA2 Founder Mutation Analysis in Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue |
|
|
|
|
|
|
|
|
|
| A ‘Nonsense’ Mutation Leads to Aberrant Splicing of hMLH1 in a German Hereditary Non-polyposis Colorectal Cancer Family |
|
|
|
|
|
|
|
|
|
| Familial Cancer (special issue) Breast Cancer Treatment and Genetics |
|
|
|
|
|
|
|
|
|
| Interleukin-10 Polymorphisms, Cancer Susceptibility and Prognosis |
|
|
|
|
|
|
|
|
|
| Germline Mutations of the hMLH1 and hMSH2 Mismatch Repair Genes in Belgian Hereditary Nonpolyposis Colon Cancer (HNPCC) Patients |
|
|
|
|
|
|
|
|
|
| BRCA1 and BRCA2: Chemosensitivity, Treatment Outcomes and Prognosis |
|
|
|
|
|
|
|
|
|
| Determinants of Preferences for Genetic Counselling in Jewish Women |
|
|
|
|
|
|
|
|
|
| Desmoid Tumors – a Characterization of Patients Seen at Mayo Clinic 1976–1999 |
|
|
|
|
|
|
|
|
|
| A Novel Exon Duplication Event Leading to a Truncating Germ-line Mutation of the APC Gene in a Familial Adenomatous Polyposis Family |
|
|
|
|
|
|
|
|
|
| Pharmacogenetics in the Management of Breast Cancer – Prospects for Individualised Treatment |
|
|
|
|
|
|
|
|
|
| Genotype Phenotype Correlation in Li-Fraumeni Syndrome Kindreds and its Implications for Management |
|
|
|
|
|
|
|
|
|
| Late-Onset Common Cancers in a Kindred with an Arg213Gln TP53 Germline Mutation |
|
|
|
|
|
|
|
|
|
| Compliance and Satisfaction with Long-Term Surveillance in Finnish HNPCC Families |
|
|
|
|
|
|
|
|
|
| Part II Regular Articles |
|
|
|
|
|
|
|
|
|
| The RET Mutation E768D Confers a Late-onset Familial Medullary Thyroid Carcinoma – Only Phenotype with Incomplete Penetrance: Implications for Screening and Management of Carrier Status |
|
|
|
|
|
|
|
|
|
| Part I Special Issue: Breast Cancer Treatment and Genetics |
|
|
|
|
|
|
|
|
|
| Oncogenetics and Interdisciplinary Collaborations: Essential for Progress |
|
|
|
|
|
|
|
|
|
| BRCA1 and BRCA2 Mutations in Breast and Ovarian Cancer Syndrome: Reflection on the Creighton University Historical Series of High Risk Families |
|
|
|
|
|
|
|
|
|
| The Value of Multi-Modal Gene Screening in HNPCC in Quebec: Three Mutations in Mismatch Repair Genes that would have not been Correctly Identified by Genomic DNA Sequencing Alone |
|
|
|
|
|
|
|
|
|
| Mutational Targets in Colorectal Cancer Cells with Microsatellite Instability |
|
|
|
|
|
|
|
|
|
| Challenges Identifying Genetic Determinants of Pediatric Cancers – the Childhood Leukemia Experience |
|
|
|
|
|
|
|
|
|
| Analysis of p27Kip1 Expression in Insulinomas Developed in Pancreatic β-cell Specific Men1 Mutant Mice |
|
|
|
|
|
|
|
|
|
| An Analysis of Unclassified Missense Substitutions in Human BRCA1 |
|
|
|
|
|
|
|
|
|
| Insights into the Molecular Basis of Human Hereditary Breast Cancer from Studies of the BRCA1 BRCT Domain |
|
|
|
|
|
|
|
|
|
| The European Opposition Against the BRCA Gene Patents* |
|
|
|
|
|
|
|
|
|
| Guidelines for Disclosing Genetic Information to Family Members: From Development to Use |
|
|
|
|
|
|
|
|
|
| Democratising Access to Genetic Services |
|
|
|
|
|
|
|
|
|
| Partnering in Oncogenetic Research – The INHERIT BRCAs Experience: Opportunities and Challenges |
|
|
|
|
|
|
|
|
|
| The Challenge of Developing Evidence-Based Genetics Health Care in Practice |
|
|
|
|
|
|
|
|
|
| Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-Analysis |
|
|
|
|
|
|
|
|
|